# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
First Country Allowing MDMA & Psilocybin For Depression, PTSD Makes Headlines On Saturday, July 1, 2023, Australia became ...
Federal Psychedelics: $75M Grant Program
Federal Psychedelics: $75M Grant Program
Psychedelics drug developer Wesana Health Holdings Inc. (OTCQB: WSNAF) announced all matters discussed at the company’s annual ...
“Investing in real estate can help expand experiential medicines like ketamine and MDMA for treating PTSD and build infrastruct...
The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those ...
As part of the recent so-called “psychedelics renaissance,” numerous celebrities, global
Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses
Lucy Scientific Discovery Inc. (NASDAQ: LSDI) has entered into a definitive asset purchase agreement with Wesana Health Holding...